Prognostic value of HRCT-based risk stratification for acute/subacute progression in polymyositis/dermatomyositis-associated interstitial lung disease

Key Points

• High HRCT scores predict acute or subacute progression in PM/DM-associated interstitial lung disease.
• The incorporation of clinical parameters into imaging algorithms enhances predictive accuracy by over 20%.
• This analysis utilized a retrospective design with a focus on patients displaying lung involvement in PM/DM.
• Improves predictive frameworks for interstitial lung disease while requiring validation across multiple centers.

Abstract